Avalyn Pharma Inc. (AVLN)
Market Open
15 Jun, 18:20
NASDAQ (NMS) NASDAQ (NMS) Primary $
30. 07
-0.01
-0.0489%
$
1.2B Market Cap
- P/E Ratio
- Div Yield
128,970 Volume
- Eps
$ 30.08
Previous Close Analysts:
Want to track AVLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead
Avalyn Pharma NASDAQ: AVLN executives outlined the company's inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies and plans to position its candidates as potential backbone therapies for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
Marketbeat | 1 week ago
